What is Envoke?
Envoke operates at the intersection of B2B SaaS and advanced simulation technology. The company specializes in the creation of interactive 3D digital twins, which serve as sophisticated virtual training platforms for complex laboratory and medical equipment. By providing high-fidelity, risk-free environments for technical training, Envoke enables organizations to enhance operational efficiency, reduce equipment downtime, and improve safety protocols. Its market position is defined by its ability to bridge the gap between physical hardware complexity and digital accessibility, catering to a diverse range of enterprise clients that require precision-based training solutions.
How much funding has Envoke raised?
Envoke has raised a total of $3.5M across 2 funding rounds:
Other Financing Round
$1.3M
Unspecified
$2.1M
Other Financing Round (2025): $1.3M with participation from Mercia Technologies and Finance Yorkshire
Unspecified (2026): $2.1M led by Mercia Technologies, Foresight Group Holdings, and Finance Yorkshire
Key Investors in Envoke
Mercia Technologies
Mercia Asset Management provides equity and debt financing to UK businesses with growth ambitions, acting as investment partners from scale-up to exit.
Foresight Group Holdings
Foresight Group Holdings is a diversified conglomerate specializing in civil engineering construction services and infrastructure development across multiple sectors.
Finance Yorkshire
Finance Yorkshire provides funding solutions including business loans and equity-linked investments to support growth and innovation for SMEs in the Yorkshire region.
What's next for Envoke?
With the successful closure of this major strategic investment, Envoke is poised to scale its engineering and sales operations to meet the increasing demand for digital twin integration. The company's strategic focus will likely shift toward expanding its library of virtual training modules and enhancing the interoperability of its platforms with existing laboratory management systems. As the industry continues to prioritize remote and virtualized training, Envoke's ability to deliver scalable, cloud-based simulation tools will be critical to maintaining its competitive advantage. Future growth will likely be driven by strategic partnerships with medical device manufacturers and research institutions, further embedding the company's technology into the standard operating procedures of global healthcare and scientific organizations.
See full Envoke company page
